http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190013555-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01f7d3d9295f6bf513bd55ec626cf461
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
filingDate 2018-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_828235bf050ac2927559731bec10044d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c166d8bef94b5385a99d66f59b7bb43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f40c910165e583409bdb07a862f0d58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d44f6eaecd3f895669afc7e255e795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aa9ac2b13becc1294437b4c29652cb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d21bd9282f02b50254b93381ac079ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b077ecca65b3409316cefc11d322377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ad68cc191747cd69e68e212c2bd437d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a32ffff17663c47107b8c2b219c5129c
publicationDate 2019-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20190013555-A
titleOfInvention Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same
abstract The present invention relates to an intermediate useful for the synthesis of an aminopyrimidine derivative or a pharmaceutically acceptable salt thereof having an activity to selectively inhibit protein kinase, particularly a mutant epidermal growth factor receptor, against protein kinase, And a manufacturing method thereof. The present invention also provides novel intermediates useful in the above process and processes for their preparation.
priorityDate 2017-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24329
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463415
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04412
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467233370
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407217
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37455
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396494
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13649

Total number of triples: 37.